|
|
||||||||
J Thorac Cardiovasc Surg 2006;132:66-71
© 2006 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Cardiac Surgery Unit, The Royal Children's Hospital, Melbourne, Victoria, Australia
b Department of Pediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Received for publication June 2, 2005; revisions received January 3, 2006; accepted for publication February 17, 2006. * Address for reprints: Christian Pierre Robert Brizard, MD, Cardiac Surgery Unit, The Royal Children's Hospital, Flemington Rd, Parkville, Victoria, 3052, Australia. (Email: christian.brizard{at}rch.org.au).
OBJECTIVE: Although homograft conduits are frequently used to establish right ventricletopulmonary artery continuity, the limited availability of small-size homografts is a significant constraint in pediatric cardiac surgery. We compared the performance of standard homograft conduits with that of surgically reduced bicuspid homograft conduits in patients undergoing repair of truncus arteriosus.
METHODS: Forty infants undergoing complete repair of truncus arteriosus with either standard homografts (n = 26) or reduced-size bicuspid homografts (n = 14) were evaluated.
RESULTS: The median downsized conduit diameter (13 mm) was similar to the standard homograft diameter (12 mm, P = .52). There were 6 early deaths and 5 late deaths, representing an overall 30-day mortality of 15% and a 5-year mortality of 25%. No deaths were directly related to homograft dysfunction. Four (29%) downsized conduits and 8 (31%) standard conduits required replacement at a median interval of 18.5 months and 42.4 months, respectively. Catheter-based interventions were required in 5 (36%) patients in the downsized group and in 3 (12%) patients in the standard group. There was no difference in freedom from surgical or catheter-based reintervention between the 2 groups (P = .42). Freedom from conduit failure (severe conduit stenosis, moderate or greater regurgitation) was 55.9% and 17.2% at 3 years in the downsized and standard groups, respectively.
CONCLUSION: The surgically downsized homograft is an excellent option when an appropriate-sized homograft is not available and might prevent morbidity associated with the use of an oversized conduit.
This article has been cited by other articles:
![]() |
J. P.V. Zachariah, F. A. Pigula, J. E. Mayer Jr, and D. B. McElhinney Right ventricle to pulmonary artery conduit augmentation compared with replacement in young children. Ann. Thorac. Surg., August 1, 2009; 88(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |